Novozymes A/S (OTCMKTS:NVZMY) Issues Earnings Results

Novozymes A/S (OTCMKTS:NVZMY) issued its quarterly earnings data on Wednesday. The biotechnology company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.79 by ($0.44), Zacks reports.

Novozymes A/S Stock Performance

NVZMY stock traded down $2.75 during mid-day trading on Wednesday, hitting $57.99. 22,199 shares of the company were exchanged, compared to its average volume of 52,642. Novozymes A/S has a 1-year low of $53.95 and a 1-year high of $75.99. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.00 and a current ratio of 1.61. The firm’s 50 day simple moving average is $62.96 and its 200 day simple moving average is $62.70.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).